Your browser doesn't support javascript.
loading
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
Cortes, J; Calvo, V; Ramírez-Merino, N; O'Shaughnessy, J; Brufsky, A; Robert, N; Vidal, M; Muñoz, E; Perez, J; Dawood, S; Saura, C; Di Cosimo, S; González-Martín, A; Bellet, M; Silva, O E; Miles, D; Llombart, A; Baselga, J.
Afiliação
  • Cortes J; Department of Medical Oncology, Vall d´Hebron University Hospital, Barcelona. Electronic address: jacortes@vhio.net.
  • Calvo V; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid.
  • Ramírez-Merino N; Department of Medical Oncology, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • O'Shaughnessy J; Department of Medical Oncology, Baylor-Charles A. Sammons Cancer Center, Texas Oncology, and US Oncology, Dallas.
  • Brufsky A; Department of Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh.
  • Robert N; Department of Medical Oncology, Virginia Cancer Specialists, US Oncology, Fairfax, USA.
  • Vidal M; Department of Medical Oncology, Vall d´Hebron University Hospital, Barcelona.
  • Muñoz E; Department of Medical Oncology, Vall d´Hebron University Hospital, Barcelona.
  • Perez J; Department of Medical Oncology, Vall d´Hebron University Hospital, Barcelona.
  • Dawood S; Department of Medical Oncology, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates.
  • Saura C; Department of Medical Oncology, Vall d´Hebron University Hospital, Barcelona.
  • Di Cosimo S; Department of Medical Oncology, Vall d´Hebron University Hospital, Barcelona.
  • González-Martín A; Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain.
  • Bellet M; Department of Medical Oncology, Vall d´Hebron University Hospital, Barcelona.
  • Silva OE; Department of Medical Oncology, University of Miami Leonard M. Miller School of Medicine, Miami, USA.
  • Miles D; Department of Medical Oncology, Mount Vernon Cancer Centre, Middlesex, UK.
  • Llombart A; Department of Medical Oncology, Arnau de Vilanova Hospital, Lérida, Spain.
  • Baselga J; Department of Medical Oncology, Massachusetts General Hospital, Boston, USA.
Ann Oncol ; 23(5): 1130-1137, 2012 May.
Article em En | MEDLINE | ID: mdl-21976387
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Anticorpos Monoclonais Humanizados Tipo de estudo: Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Anticorpos Monoclonais Humanizados Tipo de estudo: Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article